CLINICAL_TRIALS
trial_result
· 2026-02-20
Clinical Trial Update: CraniSeal Post Approval Study [Phase 4]
Summary
Phase 4 post-approval clinical trial update for CraniSeal. The study evaluating CraniSeal for cerebrospinal fluid leaks is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pramand LLC | Conditions: Leak, Cerebrospinal Fluid | Phase 4 | Status: RECRUITING